Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?

Detalles Bibliográficos
Autores principales: Savioli, Felicio, Claro, Maurício, da Silva Ramos, Fernando Jose, Pastore, Laerte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938685/
https://www.ncbi.nlm.nih.gov/pubmed/35306858
http://dx.doi.org/10.1177/10760296221087692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938685/
https://www.ncbi.nlm.nih.gov/pubmed/35306858
http://dx.doi.org/10.1177/10760296221087692

Ejemplares similares